Literature DB >> 33137677

Lipid deposition and metaflammation in diabetic kidney disease.

Alla Mitrofanova1, Antonio M Fontanella2, Sandra Merscher2, Alessia Fornoni3.   

Abstract

A critical link between metabolic disorders and a form of low-grade systemic and chronic inflammation has been recently established and named 'Metaflammation'. Metaflammation has been recognized as a key mediator of both microvascular and macrovascular complications of diabetes and as a significant contributor to the development of diabetic kidney disease (DKD). The goal of this review is to summarize the contribution of diabetes-induced inflammation and the related signaling pathways to diabetic complications, with a particular focus on how innate immunity and lipid metabolism influence each other.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Year:  2020        PMID: 33137677      PMCID: PMC7769904          DOI: 10.1016/j.coph.2020.09.004

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  133 in total

Review 1.  Role of leukotrienes in diabetic retinopathy.

Authors:  Tapan Behl; Ishneet Kaur; Anita Kotwani
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-12-07       Impact factor: 3.072

2.  Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy.

Authors:  Zeng-Mei An; Xing-Gang Dong; Yuan Guo; Jia-Liang Zhou; Tao Qin
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-06-14

3.  Intercellular adhesion molecule-1-deficient mice are resistant against renal injury after induction of diabetes.

Authors:  Shinichi Okada; Kenichi Shikata; Mitsuhiro Matsuda; Daisuke Ogawa; Hitomi Usui; Yuichi Kido; Ryo Nagase; Jun Wada; Yasushi Shikata; Hirofumi Makino
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

4.  Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.

Authors:  S Müller; S Martin; W Koenig; P Hanifi-Moghaddam; W Rathmann; B Haastert; G Giani; T Illig; B Thorand; H Kolb
Journal:  Diabetologia       Date:  2002-05-08       Impact factor: 10.122

5.  The type 1 diabetes locus Idd6 controls TLR1 expression.

Authors:  David Vallois; Christina H Grimm; Philip Avner; Christian Boitard; Ute Christine Rogner
Journal:  J Immunol       Date:  2007-09-15       Impact factor: 5.422

Review 6.  Sphingolipid metabolites in inflammatory disease.

Authors:  Michael Maceyka; Sarah Spiegel
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

7.  Serum monocyte chemoattractant protein-1 is a biomarker in patients with diabetes and periodontitis.

Authors:  Preethi Radhakrishnan; Padma Srikanth; Krishna G Seshadri; Ramya Barani; Maitreya Samanta
Journal:  Indian J Endocrinol Metab       Date:  2014-07

8.  SMPDL3b modulates insulin receptor signaling in diabetic kidney disease.

Authors:  A Mitrofanova; S K Mallela; G M Ducasa; T H Yoo; E Rosenfeld-Gur; I D Zelnik; J Molina; J Varona Santos; M Ge; A Sloan; J J Kim; C Pedigo; J Bryn; I Volosenco; C Faul; Y H Zeidan; C Garcia Hernandez; A J Mendez; I Leibiger; G W Burke; A H Futerman; L Barisoni; Y Ishimoto; R Inagi; S Merscher; A Fornoni
Journal:  Nat Commun       Date:  2019-06-19       Impact factor: 14.919

9.  The origin of circulating CD36 in type 2 diabetes.

Authors:  M J Alkhatatbeh; A K Enjeti; S Acharya; R F Thorne; L F Lincz
Journal:  Nutr Diabetes       Date:  2013-02-04       Impact factor: 5.097

10.  High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.

Authors:  Mohan R Dasu; Sridevi Devaraj; Ling Zhao; Daniel H Hwang; Ishwarlal Jialal
Journal:  Diabetes       Date:  2008-07-23       Impact factor: 9.461

View more
  1 in total

1.  Bioinformatics prediction and experimental verification of key biomarkers for diabetic kidney disease based on transcriptome sequencing in mice.

Authors:  Jing Zhao; Kaiying He; Hongxuan Du; Guohua Wei; Yuejia Wen; Jiaqi Wang; Xiaochun Zhou; Jianqin Wang
Journal:  PeerJ       Date:  2022-09-20       Impact factor: 3.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.